List of Journal Club 2021-2022
Online event
First-year Ph.D. student, Eleonora Testi, will present the results of the article "Ribosome-Templated Azide-Alkyne Cycloadditions Using Resistant Bacteria as Reaction Vessels: in Cellulo Click Chemistry". Correlator Giambattista Marotta
Drug Discovery Course by Alumni
Online event
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Course, #6 Ramona Trastullo, Analytical Tech Transfer Lead and Project Manager in Biogen
Drug Discovery Course by Alumni
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Course #5 Marcello Di Sabatino, Innovative Technology & Pharma Projects Senior Specialist R&D – Chemical, Pharmaceutical & Nutraceutical Technology in Alfasigma
Drug Discovery Course by Alumni
Online event
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Course, meeting #4 Daniela Pizzirani, Principal Scientist Medicinal Chemistry in Chiesi Farmaceutici
Drug Discovery Course by Alumni
Online event
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Course, meeting #3 Therapy landscape"Federica Prati, Medicinal Chemistry Scientist in Angelini Pharma
Drug Discovery Course by Alumni
Online event
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Cours, meeting #2 Maria Rosaria Ferraro, Computational Chemist in Sosei Heptares
Drug Discovery Course by Alumni
Online event
Drug Discovery Course is held by B2F2 Alumni as industrial experts from pharma and biotech companies. Drug Discovery Course, meeting #1 Marco De Cecco, Principal Scientist in Astellas Institute for Regenerative Medicine (AIRM) Title:"A Biotechnology Ph.D. in the Cell Therapy landscape"
Polo didattico Navile, via della Beverara 123/1, Aula Magna
During the first B2F2 Retreat, Ph.D. students of the XXXV cycle will discuss their doctoral projects through a presentation followed by questions from the external examiners
The CMB-B2F2 Joint Seminar Series
Microsoft Teams
We are glad to announce that Prof. Kelly Chibale from University of Cape Town (Cape Town, South Africa) will be the 4th speaker at CMB-B2F2 Join Seminar, presenting the mechanism of action studies to identify targets of whole cell actives in Malaria and Tuberculosis drug discovery
Seminars
Microsoft Teams
The aim of the School is to spread among young people in education and among those who are already working in this field, how to best use the tools offered by the most advanced research and updated .
The CMB-B2F2 Joint Seminar Series
Microsoft Teams
Prof. Matteo Calvaresi (University of Bologna), 3rd speaker of CMB-B2F2 Joint Seminar will present the BIOTAXI - Proteins as “Trojan Horses” for theranostic applications.
The CMB-B2F2 Joint Seminar Series
Microsoft Teams
The second speaker Prof.ssa Gabriela Costantin (University of Verona) will share her interesting research topic about targeting immune mechanisms for the treatment of Alzheimer’s disease.